Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an In Vitro study

[1]  Kirandeep Kaur,et al.  Quinolines and structurally related heterocycles as antimalarials. , 2010, European journal of medicinal chemistry.

[2]  R. Moreira,et al.  Primaquine revisited six decades after its discovery. , 2009, European journal of medicinal chemistry.

[3]  K. Pandey,et al.  Protective Role of Myricetin on Markers of Oxidative Stress in Human Erythrocytes Subjected to Oxidative Stress , 2009, Natural product communications.

[4]  G. Bartosz,et al.  N-chloroamino acids cause oxidative protein modifications in the erythrocyte membrane , 2008, Mechanisms of Ageing and Development.

[5]  K. Fung,et al.  Pro-oxidative effects of Chinese herbal medicine on G6PD-deficient erythrocytes in vitro. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[6]  J. M. Lanao,et al.  In vitro studies of amikacin-loaded human carrier erythrocytes. , 2008, Translational research : the journal of laboratory and clinical medicine.

[7]  Kamalinder K. Singh,et al.  Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. , 2008, International journal of pharmaceutics.

[8]  M. Hamidi,et al.  Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b. , 2007, International journal of pharmaceutics.

[9]  Mehrdad Hamidi,et al.  Applications of carrier erythrocytes in delivery of biopharmaceuticals. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Z. Cui,et al.  Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy. , 2005, International journal of pharmaceutics.

[11]  N. K. Jain,et al.  Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. , 2005, International journal of pharmaceutics.

[12]  J. M. Lanao,et al.  Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis. , 2004, Blood cells, molecules & diseases.

[13]  A. Jayakrishnan,et al.  Preparation and in vitro evaluation of primaquine-conjugated gum arabic microspheres. , 2004, Biomacromolecules.

[14]  K. Becker,et al.  Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. , 2004, International journal for parasitology.

[15]  D. Lu,et al.  Safety and utilization of blood components as therapeutic delivery systems. , 2003, Current pharmaceutical biotechnology.

[16]  P. Moitra,et al.  Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes , 2002, FEBS letters.

[17]  A. Zanella,et al.  Cellular contamination of plasma collected with various apheresis systems. , 2001, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[18]  M. Rouini,et al.  In Vitro Characterization of Human Intact Erythrocytes Loaded by Enalaprilat , 2001, Drug delivery.

[19]  P. Quinn,et al.  Phospholipid signaling in apoptosis: peroxidation and externalization of phosphatidylserine. , 2000, Toxicology.

[20]  S. A. Sande,et al.  Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design. , 2000, International journal of pharmaceutics.

[21]  U. Dumaswala,et al.  Effect of a glycerol-containing hypotonic medium on erythrocyte phospholipid asymmetry and aminophospholipid transport during storage. , 1997, Biochimica et Biophysica Acta.

[22]  Sanjay K Jain,et al.  Engineered Erythrocytes As A Drug Delivery System , 1997 .

[23]  F. Puisieux,et al.  Interpretation and prediction of plasma levels of primaquine following transdermal delivery in Swiss mice , 1997 .

[24]  H. Roth,et al.  Supplementation with vitamin C, vitamin E or beta-carotene influences osmotic fragility and oxidative damage of erythrocytes of zinc-deficient rats. , 1997, The Journal of nutrition.

[25]  A. Schroit,et al.  Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. , 1997, Blood.

[26]  H. Fessi,et al.  Primaquine-loaded poly(lactide) nanoparticles : physicochemical study and acute tolerance in mice , 1995 .

[27]  T. Ishikawa,et al.  Presence of membrane-bound proteinases that preferentially degrade oxidatively damaged erythrocyte membrane proteins as secondary antioxidant defense. , 1994, Biochimica et biophysica acta.

[28]  N. Jain,et al.  Erythrocytes as carriers of primaquine-preparation: characterization and evaluation , 1992 .

[29]  F. Kuypers,et al.  Lipid peroxidation in human red cells. , 1989, Seminars in hematology.

[30]  S. Schrier,et al.  Studies on the effect of vanadate on endocytosis and shape changes in human red blood cells and ghosts. , 1986, Blood.

[31]  I. Junga,et al.  Drug-induced endocytosis of neonatal erythrocytes. , 1985, Blood.

[32]  H. Alpar,et al.  Therapeutic possibilities of drugs encapsulated in erythrocytes , 1984 .

[33]  S. Jain.  The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. , 1984, The Journal of biological chemistry.

[34]  S. Schrier,et al.  Calcium distribution within human erythrocytes during endocytosis. , 1980, Blood.

[35]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[36]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[37]  V. Kadam,et al.  Drug loaded erythrocytes: as novel drug delivery system. , 2008, Current pharmaceutical design.

[38]  B. Bukowska,et al.  Phenoxyherbicides induce production of free radicals in human erythrocytes: oxidation of dichlorodihydrofluorescine and dihydrorhodamine 123 by 2,4-D-Na and MCPA-Na. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[39]  N. Udupa,et al.  Effective drug targeting by Erythrocytes as Carrier Systems , 2007 .

[40]  V. Dixit,et al.  Magnetically Guided Rat Erythrocytes Bearing Isoniazid: Preparation, Characterization, and Evaluation , 1997 .

[41]  N. Venkatesan,et al.  RESEALED ERYTHROCYTES : DRUG CARRIER POTENTIALS AND BIOMEDICAL APPLICATIONS , 1996 .

[42]  E. Stadtman,et al.  Carbonyl assays for determination of oxidatively modified proteins. , 1994, Methods in enzymology.

[43]  H. Eichler,et al.  Release of vitamin B12 from carrier erythrocytes in vitro , 1985, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[44]  A. Zanella,et al.  A new test for the laboratory diagnosis of spherocytosis. , 1984, Acta haematologica.

[45]  S. Schrier,et al.  Requirements of drug-induced endocytosis by intact human erythrocytes. , 1978, Blood cells.